Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

620 ARTÍCULOS , VIENDO DEL 61 AL 75

Amyloid-β and tau aggregation dual-inhibitors: A synthetic and structure-activity relationship focused review

Malafaia D, Albuquerque HMT, Silva AMS.

Eur J Med Chem. 2021 Mar 15;214:113209. doi: 10.1016/j.ejmech.2021.113209. Epub 2021 Jan 25.

Patient-derived iPSCs, a reliable in vitro model for the investigation of Alzheimer's disease

Amponsah AE, Guo R, Kong D, Feng B, He J, Zhang W, Liu X, Du X, Ma Z, Liu B, Ma J, Cui H.

Rev Neurosci. 2021 Feb 1;32(4):379-402. doi: 10.1515/revneuro-2020-0065. Print 2021 Jun 25.

The role of microbial infection in the pathogenesis of Alzheimer's disease and the opportunity for protection by anti-microbial peptides

Li F, Hearn M, Bennett LE.

Crit Rev Microbiol. 2021 Mar;47(2):240-253. doi: 10.1080/1040841X.2021.1876630. Epub 2021 Feb 8.

The Application of Seaweed Polysaccharides and Their Derived Products with Potential for the Treatment of Alzheimer's Disease

Bauer S, Jin W, Zhang F, Linhardt RJ.

Mar Drugs. 2021 Feb 4;19(2):89. doi: 10.3390/md19020089.

Stem Cell Therapies in Alzheimer's Disease: Applications for Disease Modeling

Si Z, Wang X.

J Pharmacol Exp Ther. 2021 May;377(2):207-217. doi: 10.1124/jpet.120.000324. Epub 2021 Feb 8.

Nutrition-Based Approaches in Clinical Trials Targeting Cognitive Function: Highlights of the CTAD 2020

Giudici KV.

J Prev Alzheimers Dis. 2021;8(2):118-122. doi: 10.14283/jpad.2021.6.

Pharmacological Approaches for the Modulation of the Potassium Channel K(V)4.x and KChIPs

Cercós P, Peraza DA, Benito-Bueno A, Socuéllamos PG, Aziz-Nignan A, Arrechaga-Estévez D, Beato E, Peña-Acevedo E, Albert A, González-Vera JA, Rodríguez Y, Martín-Martínez M, Valenzuela C, Gutiérrez-Rodríguez M.

Int J Mol Sci. 2021 Jan 31;22(3):1419. doi: 10.3390/ijms22031419.

Potential of Naturally Derived Alkaloids as Multi-Targeted Therapeutic Agents for Neurodegenerative Diseases

Kong YR, Tay KC, Su YX, Wong CK, Tan WN, Khaw KY.

Molecules. 2021 Jan 30;26(3):728. doi: 10.3390/molecules26030728.

Trace element alterations in Alzheimer's disease: A review

Cilliers K.

Clin Anat. 2021 Jul;34(5):766-773. doi: 10.1002/ca.23727. Epub 2021 Feb 21.

Multi-Target Drug Design of Anti-Alzheimer's Disease based on Tacrine

Tian S, Huang Z, Meng Q, Liu Z.

Mini Rev Med Chem. 2021;21(15):2039-2064. doi: 10.2174/1389557521666210212151127.

Xanthone: Potential Acetylcholinesterase Inhibitor for Alzheimer's Disease Treatment

Vanessa VV, Mah SH.

Mini Rev Med Chem. 2021;21(17):2507-2529. doi: 10.2174/1389557521666210212152514.

Cellular and Molecular Mechanisms of Dementia: Decoding the Causal link of Diabetes Mellitus in Alzheimer's Disease

Rasool M, Malik A, Waquar S, Zaheer A, Asif M, Iqbal Z, Gauthaman K, Kamal MA, Pushparaj PN.

CNS Neurol Disord Drug Targets. 2021;20(7):602-612. doi: 10.2174/1871527320666210212114116.

Discovery of Atabecestat (JNJ-54861911): A Thiazine-Based β-Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitor Advanced to the Phase 2b/3 EARLY Clinical Trial

Koriyama Y, Hori A, Ito H, Yonezawa S, Baba Y, Tanimoto N, Ueno T, Yamamoto S, Yamamoto T, Asada N, Morimoto K, Einaru S, Sakai K, Kanazu T, Matsuda A, Yamaguchi Y, Oguma T, Timmers M, Tritsmans L, Kusakabe KI, Kato A, Sakaguchi G.

J Med Chem. 2021 Feb 25;64(4):1873-1888. doi: 10.1021/acs.jmedchem.0c01917. Epub 2021 Feb 15.

Study of Nutraceuticals and Phytochemicals for the Management of Alzheimer's Disease: A Review

Ahmad SS, Khalid M, Kamal MA, Younis K.

Curr Neuropharmacol. 2021;19(11):1884-1895. doi: 10.2174/1570159X19666210215122333.

Recent Multi-target Approaches on the Development of Anti- Alzheimer's Agents Integrating Metal Chelation Activity

Chaves S, Várnagy K, Santos MA.

Curr Med Chem. 2021;28(35):7247-7277. doi: 10.2174/0929867328666210218183032.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias